While certain cancer types (ie, HNC and HPBC) exhibited a higher rate of TERT promoter mutations in primary tumor samples compared to metastatic samples, mutations were more prevalent in metastatic samples of melanoma and thyroid cancer compared to primary tumors. This evidence concerns the gene TERT and thyroid cancer.